# Precision Therapy Versus Standard Therapy in AML and MDS in Elderly

> **NCT05025098** · PHASE2 · RECRUITING · sponsor: **University Hospital, Akershus** · enrollment: 36 (estimated)

## Conditions studied

- AML, Adult
- MDS

## Interventions

- **DRUG:** Standard therapy
- **DRUG:** Precision therapy

## Key facts

- **NCT ID:** NCT05025098
- **Lead sponsor:** University Hospital, Akershus
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-06-22
- **Primary completion:** 2026-06-10
- **Final completion:** 2027-06-10
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2021-08-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05025098

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05025098, "Precision Therapy Versus Standard Therapy in AML and MDS in Elderly". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05025098. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*